Susquehanna International Group’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.69M | Buy |
328,726
+299,221
| +1,014% | +$5.18M | ﹤0.01% | 1180 |
|
|
2025
Q1 | $645K | Buy |
29,505
+3,288
| +13% | +$71.9K | ﹤0.01% | 4003 |
|
|
2024
Q4 | $837K | Sell |
26,217
-145,575
| -85% | -$4.65M | ﹤0.01% | 3265 |
|
|
2024
Q3 | $4.95M | Sell |
171,792
-307,171
| -64% | -$8.86M | ﹤0.01% | 1052 |
|
|
2024
Q2 | $18.4M | Buy |
478,963
+234,702
| +96% | +$9M | ﹤0.01% | 420 |
|
|
2024
Q1 | $14.4M | Sell |
244,261
-138,571
| -36% | -$8.15M | ﹤0.01% | 487 |
|
|
2023
Q4 | $22.9M | Buy |
382,832
+10,047
| +3% | +$601K | ﹤0.01% | 355 |
|
|
2023
Q3 | $14.2M | Buy |
372,785
+56,875
| +18% | +$2.16M | ﹤0.01% | 558 |
|
|
2023
Q2 | $28.8M | Buy |
315,910
+234,114
| +286% | +$21.3M | 0.01% | 301 |
|
|
2023
Q1 | $5.4M | Buy |
81,796
+50,064
| +158% | +$3.3M | ﹤0.01% | 1071 |
|
|
2022
Q4 | $1.64M | Sell |
31,732
-26,128
| -45% | -$1.35M | ﹤0.01% | 1778 |
|
|
2022
Q3 | $3.95M | Buy |
57,860
+4,080
| +8% | +$279K | ﹤0.01% | 1013 |
|
|
2022
Q2 | $2.43M | Sell |
53,780
-21,855
| -29% | -$988K | ﹤0.01% | 1479 |
|
|
2022
Q1 | $3.84M | Buy |
75,635
+6,886
| +10% | +$350K | ﹤0.01% | 1382 |
|
|
2021
Q4 | $3.25M | Sell |
68,749
-40,661
| -37% | -$1.92M | ﹤0.01% | 1532 |
|
|
2021
Q3 | $3.61M | Buy |
109,410
+80,641
| +280% | +$2.66M | ﹤0.01% | 1421 |
|
|
2021
Q2 | $1.82M | Buy |
28,769
+2,846
| +11% | +$180K | ﹤0.01% | 2182 |
|
|
2021
Q1 | $1.11M | Buy |
25,923
+12,183
| +89% | +$523K | ﹤0.01% | 2858 |
|
|
2020
Q4 | $786K | Sell |
13,740
-29,103
| -68% | -$1.66M | ﹤0.01% | 2871 |
|
|
2020
Q3 | $1.29M | Sell |
42,843
-45,818
| -52% | -$1.38M | ﹤0.01% | 1903 |
|
|
2020
Q2 | $2.9M | Sell |
88,661
-37,133
| -30% | -$1.21M | ﹤0.01% | 1163 |
|
|
2020
Q1 | $3.37M | Sell |
125,794
-5,538
| -4% | -$148K | ﹤0.01% | 926 |
|
|
2019
Q4 | $4.02M | Buy |
131,332
+68,034
| +107% | +$2.08M | ﹤0.01% | 972 |
|
|
2019
Q3 | $1.52M | Buy |
63,298
+28,322
| +81% | +$682K | ﹤0.01% | 1538 |
|
|
2019
Q2 | $886K | Buy |
+34,976
| New | +$886K | ﹤0.01% | 2216 |
|